Market Currents
Nektar Therapeutics (NKTR) agrees to sell royalties for its Cimzia and Mircera drugs to Royalty...
-
Wednesday, February 29, 2012, 8:38 AM ETNektar Therapeutics (NKTR) agrees to sell royalties for its Cimzia and Mircera drugs to Royalty Pharma for $124M. The company plans to use the net proceeds of the transaction towards the repayment of its $215M in convertible debt. Shares are currently under a trading halt.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
